The SARS-CoV-2 / Influenza A/B / RSV rapid test is a rapid diagnostic test (RDT) for professional use only, allowing the detection of Influenza A/B + COVID-19 + RSV by performing a single sample collection on a patient.
✓ Cover a wider range of respiratory viruses in a single test
✓ Easy to use, results in 10 minutes maximum
✓ Nasal or nasopharyngeal swab
✓ Test listed on the EU common list of antigen detection tests for COVID-19 diagnosis (Page 61): Common list
| Reference | ISIR-9334 |
ISIR-9334C |
| Product name | Professional use antigen test Triplex COVID / INFLUENZA A&B / RSV for adults |
Professional use antigen test Triplex COVID / FLU A&B / RSV for children |
|
Product sheet |
||
|
Statement ofcompliance THIS |
||
|
Noticed‘use (FR) |
||
|
Report ofevaluation Clinical Performance (EN) |
On request |
|
|
Packaging |
25 Kits per box, 32 boxes per carton // 800 Kits per carton 620*480*380mm, 15kg/carton |
|
|
Contents of the box |
25 x test cassettes (Result Reader) 25 x sterile nasal swabs 25 x extraction tubes 25 x drippers |
25 x test cassettes (Result Reader) 25 x sterile short nasal swabs for children 25 x extraction tubes 25 x drippers |
|
Data clinics |
Sars-Cov-2 Clinical sensitivity: 97.12% |
|
|
Influenza A: Clinical sensitivity: 96.60% Flu B: Clinical sensitivity: 97.22% |
||
|
VRS: Clinical sensitivity: 97.78% |
||
*Given the current regulations, the collection of nasopharyngeal samples for antigen tests is entrusted to doctors, pharmacists, state-certified nurses, as well as other healthcare professionals (See the PDF document - Other_Healthcare_Professionals_authorized according to art.25 / Decree of 10.07.20).